These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

996 related items for PubMed ID: 6355296

  • 1. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 2. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA, Warren KA, Tam M, Frank MM.
    J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
    [Abstract] [Full Text] [Related]

  • 4. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK, Johnson RC, Dalmasso AP.
    J Immunol; 1991 Jun 01; 146(11):3964-70. PubMed ID: 2033266
    [Abstract] [Full Text] [Related]

  • 5. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
    Ward CK, Inzana TJ.
    J Immunol; 1994 Sep 01; 153(5):2110-21. PubMed ID: 8051416
    [Abstract] [Full Text] [Related]

  • 6. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL, Duncan RL, Morrison DC.
    J Immunol; 1986 Aug 15; 137(4):1329-35. PubMed ID: 3525676
    [Abstract] [Full Text] [Related]

  • 7. Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.
    Gadd KJ, Reid KB.
    Immunology; 1981 Jan 15; 42(1):75-82. PubMed ID: 6780451
    [Abstract] [Full Text] [Related]

  • 8. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
    Joiner KA, Goldman R, Schmetz M, Berger M, Hammer CH, Frank MM, Leive L.
    J Immunol; 1984 Jan 15; 132(1):369-75. PubMed ID: 6197449
    [Abstract] [Full Text] [Related]

  • 9. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    Joiner K, Brown E, Hammer C, Warren K, Frank M.
    J Immunol; 1983 Feb 15; 130(2):845-9. PubMed ID: 6848598
    [Abstract] [Full Text] [Related]

  • 10. Toxoplasma gondii: mechanism of resistance to complement-mediated killing.
    Fuhrman SA, Joiner KA.
    J Immunol; 1989 Feb 01; 142(3):940-7. PubMed ID: 2643665
    [Abstract] [Full Text] [Related]

  • 11. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA, Hammer CH, Brown EJ, Cole RJ, Frank MM.
    J Exp Med; 1982 Mar 01; 155(3):797-808. PubMed ID: 6801179
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.
    Joiner KA, Scales R, Warren KA, Frank MM, Rice PA.
    J Clin Invest; 1985 Nov 01; 76(5):1765-72. PubMed ID: 3932472
    [Abstract] [Full Text] [Related]

  • 13. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.
    Kochi SK, Johnson RC.
    Infect Immun; 1988 Feb 01; 56(2):314-21. PubMed ID: 3276623
    [Abstract] [Full Text] [Related]

  • 14. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov 01; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
    Joiner KA, Schmetz MA, Goldman RC, Leive L, Frank MM.
    Infect Immun; 1984 Jul 01; 45(1):113-7. PubMed ID: 6203836
    [Abstract] [Full Text] [Related]

  • 16. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T, Frisk A, Purvèn M, Nilsson LA.
    Microb Pathog; 1995 Jan 01; 18(1):37-51. PubMed ID: 7783597
    [Abstract] [Full Text] [Related]

  • 17. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule.
    Jarvis GA, Griffiss JM.
    J Immunol; 1991 Sep 15; 147(6):1962-7. PubMed ID: 1909736
    [Abstract] [Full Text] [Related]

  • 18. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA, Ruddy S.
    J Immunol; 1981 Jan 15; 126(1):7-10. PubMed ID: 6778918
    [Abstract] [Full Text] [Related]

  • 19. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance.
    Pramoonjago P, Kaneko M, Kinoshita T, Ohtsubo E, Takeda J, Hong KS, Inagi R, Inoue K.
    J Immunol; 1992 Feb 01; 148(3):827-36. PubMed ID: 1730875
    [Abstract] [Full Text] [Related]

  • 20. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A, Ahmed HJ, Van Dyck E, Lagergård T.
    Microb Pathog; 1998 Aug 01; 25(2):67-75. PubMed ID: 9712686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.